Predictive Diagnostics

US based C₂N Diagnostics expands Alzheimer’s diagnostics into Japan

Expands into Japan through Mediford Corporation partnership with Precivity blood testing for Alzheimer’s Disease and brain research market...

Neuberg Diagnostics forms JV with Sehgal Path Lab to expand haemato-oncology segment

The collaboration will see Sehgal Path Lab rebranded as Neuberg Sehgal Path Lab...

Owlstone Medical secures $6.5 M to develop breath-based diagnostics for infectious disease

Developing new cost-effective detection technologies for volatile organic compounds (VOCs)...

IIT Jodhpur develops framework for smartphones-assisted glucose testing device

Allowing diagnostic information to easily be available straight on the phone by simply using an app...

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Cognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors...

Vygon spearheads neonatal safety in India with groundbreaking Nutrisafe2 system

First company in the country to launch the enhanced neonatal feeding system...

Johnson & Johnson Innovation names finalists in atopic advancements QuickPitch

Johnson & Johnson QuickPitch finalists revealed in atopic advancements...

“Early diagnosis through advanced screening tech, coupled with heightened awareness is crucial”

The oncology market in India is steadily growing, driven by an increasing cancer incidence and a strong demand for advanced treatments. However, there remains substantial untapped potential, primarily in improving access to cutting-edge therapies and expanding reach to underserved regions. Glenmark Pharma, with its patient-centric approach and innovative solutions, has been steadily increasing its market share by introducing high-quality and affordable cancer drugs. Alok Malik, President & ...